Understanding Trans Platinum Complexes As Potential Antitumor Drugs Beyond Targeting DNA
Overview
Authors
Affiliations
This focused review is devoted to our advances in developing trans platinum complexes as antitumoral complexes, in particular those bearing aliphatic amines. It includes some fundamental aspects of the understanding of non conventional metallodrug mechanism. The perspective is arranged by those fundamental aspects and within each section only the most successful examples have been included and also those in which clearly SAR's (structure activity relationships) have been observed.
Melones-Herrero J, Alcala S, Ruiz-Canas L, Benitez-Buelga C, Batres-Ramos S, Cales C Commun Biol. 2024; 7(1):353.
PMID: 38519773 PMC: 10959927. DOI: 10.1038/s42003-024-06052-5.
Tabatabai A, Dehghanian E, Mansouri-Torshizi H Biometals. 2022; 35(2):245-266.
PMID: 35039973 DOI: 10.1007/s10534-022-00362-z.
Infante-Tadeo S, Rodriguez-Fanjul V, Habtemariam A, Pizarro A Chem Sci. 2021; 12(27):9287-9297.
PMID: 34349898 PMC: 8278929. DOI: 10.1039/d1sc01939b.
Sgarbossa P, Sliwinska-Hill U, Guedes da Ilva M, Bazanow B, Pawlak A, Jackulak N Materials (Basel). 2019; 12(23).
PMID: 31779206 PMC: 6926962. DOI: 10.3390/ma12233907.
van Rixel V, Busemann A, Wissingh M, Hopkins S, Siewert B, Van de Griend C Angew Chem Int Ed Engl. 2019; 58(28):9378-9382.
PMID: 31046177 PMC: 6618160. DOI: 10.1002/anie.201814532.